Kasher Meron, Michal http://orcid.org/0000-0001-8149-8514
Eizenstein, Sapir
Cukierman-Yaffe, Tali
Oieru, Dan http://orcid.org/0009-0006-1432-1659
Article History
Received: 10 November 2023
Revised: 19 March 2024
Accepted: 20 March 2024
First Online: 22 April 2024
Competing interests
: MKM reports receipt of speaker fees from Novo Nordisk, LTD, Eli Lilly; Sanofi and Boehringer Ingelheim. DO reports receipt of speaker fees from Novo Nordisk, LTD and Boehringer Ingelheim. SE reports no CI. TCY reports receipt of speaker fees from Novo Nordisk, LTD, Eli Lilly; Sanofi and Boehringer Ingelheim, Medtronic, Merck Sharp & Dhome and AstraZeneca.